POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 107 | / | 2020 | ||||||||
Date of issue: | 2020-09-25 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Notification on the terms and conditions for distribution of the dividend | |||||||||||
Official market - legal basis | |||||||||||
art. 56. 1. 2 of Act on Public Offering. | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
In accordance with Art. 115c, para. 4 of the Law on Public Offering of Securities “Sopharma” AD hereby notifies all shareholders of the Company about the decision of the Extraordinary General Meeting of shareholders of “Sopharma” AD that took place on September 25, 2020 from 11:00 a.m. (UTC 8:00 a.m.) regarding the amount and type of dividend distributed and the terms and conditions for its distribution: The General Meeting of shareholders approves the proposal by the Board of Directors for the distribution of 6-month dividend at the amount of 0.04 BGN /four stotinki / per share. The persons eligible for dividend are those present in the register of the “Central Depository” AD 14 days after the day of the General Meeting on which the 6-Month Financial Report for the first half of 2020 was approved and the decision for dividend was taken, namely October 9, 2020 (record date) – ex dividend date October 8, 2020. The dividend payment will start on November 23, 2020 (Monday). In accordance with the Regulations of the “Central Depository” AD, the dividend shall be paid out as follows: for shareholders with client accounts at an investment intermediary – through the investment intermediary, for shareholders without accounts at an investment intermediary - through the branches of “Eurobank EFG – Bulgaria” AD /Postbank/ in the country. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
3JR_EGM_25092020_dividend_EN-espi.pdf | Notification on the terms and conditions for distribution of the dividend |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2020-09-25 | Ognian Donev | Executive Director |